Hydrix is one of the most undervalued shares in ASX and losing its ground after a credible hype in August 2020 where share price rose from $0.1 to its current level. The CEO has promised that 2021 will be a promising year but I don't see any energy in this share besides AngleMed is currently in process of getting a TGA approval. Historically, HYD was trading >$1 in 2018, however, it's products are yet to convince the market that it is a growth company. I'm losing my patience, but still hopeful that it could do better in 2021. Anyone can convince me that I should be still holding this share in 2021
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.091M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 333444 | 1.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.6¢ | 100000 | 1 |
View Market Depth
| Last trade - 16.21pm 11/09/2025 (20 minute delay) ? |
| HYD (ASX) Chart |
Day chart unavailable